^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AXA-042

    i
    Other names: AXA-042
    Associations
    News
    Trials
    Company:
    Axelia Oncology
    Drug class:
    TLR2 agonist, TLR6 agonist
    Related drugs:
    Associations
    News
    Trials